Five Prime Therapeutics, Inc.
FPRX
FPRX was delisted on the 15th of April, 2021.
93 hedge funds and large institutions have $425M invested in Five Prime Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 42 increasing their positions, 11 reducing their positions, and 8 closing their positions.
282% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 11
275% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 8
31% more funds holding
Funds holding: 71 → 93 (+22)
15% more capital invested
Capital invested by funds: $369M → $425M (+$56M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$24.9M |
| 2 |
State Street
Boston,
Massachusetts
|
+$22.9M |
| 3 |
Millennium Management
New York
|
+$17.8M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$17.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$28.4M |
| 2 |
SAM
Senzar Asset Management
New York
|
-$8.98M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$8.16M |
| 4 |
MSA
Mason Street Advisors
Milwaukee,
Wisconsin
|
-$2.65M |
| 5 |
QF
QVT Financial
New York
|
-$2.32M |
FPRX Hedge Fund Activity: Q1 2015 in Review
93 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q1 2015, worth a combined $425M — up 15% from $369M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new FPRX positions and 8 closed out — a net gain of 22 holders — while 42 added to existing stakes and 11 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $24.9M. The largest seller was TPG Group Holdings (SBS) Advisors, exiting entirely with an estimated $28.4M sold.
- 93 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q1 2015, up from 71 in Q4 2014.
- Funds reported $425M of Five Prime Therapeutics, Inc. stock for Q1 2015, up 15% quarter-over-quarter.
- 30 funds opened new Five Prime Therapeutics, Inc. positions in Q1 2015 and 8 closed out, a net change of +22 holders.
- The largest Five Prime Therapeutics, Inc. buyer in Q1 2015 was Wellington Management Group, an estimated $24.9M added.
- The largest Five Prime Therapeutics, Inc. seller in Q1 2015 was TPG Group Holdings (SBS) Advisors, an estimated $28.4M sold.
Based on aggregated 13F filings for Q1 2015.